Clinical usefulness of serum Mac-2 binding protein glycosylation isomer (M2BPGi) as a novel biomarker in respiratory diseases
Not Applicable
- Conditions
- Respiratory diseases
- Registration Number
- JPRN-UMIN000022606
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are unable to get informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of serum M2BPGi level between respiratory diseases (e.g. asthma, COPD, interstitial pneumonia) and normal control
- Secondary Outcome Measures
Name Time Method To investigate correlation between serum M2BPGi and clinical characteristics, pulmonary function tests, FeNO, Chest HRCT findings in respiratory diseases.